article thumbnail

Vertex signs licence deal with CRISPR Therapeutics for diabetes therapies

Pharmaceutical Technology

The gene-editing technology allows for precise, directed changes to genomic DNA. Under the terms of the deal, the company will receive non-exclusive rights to CRISPR/Cas9, a gene-editing technology of CRISPR Therapeutics, for the development of potentially curative T1D cell therapies. The system comprises the Cas9 enzyme and a guide RNA.

article thumbnail

Treatment Reverses Young Man’s Type 1 Diabetes. Will It Last?

The Pharma Data

7, 2020 — After starting a drug that’s officially approved to treat a type of blood cancer, a young man with type 1 diabetes was able to stop using insulin. He’s been off insulin since August 2018 — more than two years. WEDNESDAY, Oct. No treatments are approved for reversing type 1 diabetes.

Insulin 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Chipscreen and HISUN reach a strategic cooperation

The Pharma Data

As the world’s first PPAR pan agonist that completed two confirmatory phase III clinical trials, Chiglitazar Sodium has shown significant and long-lasting hypoglycemic effects in a series of clinical studies, as well as other comprehensive effects including significant insulin sensitization and blood lipid regulation.

Insulin 40
article thumbnail

Genomics Market: Rising Government Expenditure in Genomics R&D to Boost the Global Market Wilmington, Delaware, United States, Transparency Market Research Inc.: The global genomics market is projected to grow at a promising rate from 2021 to 2031. In-vitro Toxicology Assays Market: Witnessing Moderate Growth during the Forecast Period [2021-2031] The global in-vitro toxicology assays market is expected to witness moderate growth during the forecast period between 2021 and 2031. Insulin Delivery Devices Market: Increase in the Prevalence Rate of Diabetes and Related Diseases Across the World to Drive the Market Wilmington, Delaware, United States, Transparency Market Research Inc.: Patient suffering from either type of diabetes mellitus require insulin to regulate adequate glucose level in the blood. Invisible Orthodontics Market: Increase in Focus on Esthetic Dentistry is Projected to Drive the Global Market Wilmington, Delaware, United States, Transparency Market Research Inc.: According to the report, the

BioSpace

Rather than selling, Novartis could spin Sandoz off into its own separate entity with its own listing on a stock exchange.

article thumbnail

Creating Future of MedTech Industry with Artificial Intelligence

Delveinsight

In May 2020, Freenome initiated AI-EMERGE, a clinical study for the AI-Genomics blood test has been completed, which collected samples from up to 3,000 patients in the US and Canada. The device is worn on the patients’ body, which contains a biharmonic cartridge in it that carries insulin and glucagon.

Protein 56
article thumbnail

Top 30 New Medical Devices of 2024

XTalks

Illumina says TruSight Oncology Comprehensive is the first US FDA-approved, distributable comprehensive genomic profiling IVD kit with pan-cancer companion diagnostic claims. Users can also manually log details such as blood glucose readings, meals, exercise or insulin doses. The device is half the size of Medtronics previous CGMs.

article thumbnail

Excellence Awards 2022 – Winners Announced!

Pharmaceutical Technology

The two companies have signed a five-year collaboration to leverage genomics and artificial intelligence (AI) to discover and develop new treatments for diseases with unmet medical needs. Deerfield and Illumina win the Research and Development award this year due to their commitment to research into AI-driven therapies. Civica JAAQ Sanofi.

Insulin 130